Biobank: who’d bank on it?

Konrad Jamrozik, David P Weller and Richard F Heller
Med J Aust 2005; 182 (2): . || doi: 10.5694/j.1326-5377.2005.tb06575.x
Published online: 17 January 2005

It is truly a bold concept — to recruit 1% of the UK population into a massive cohort study — but, 1000 days into the project, not a single participant had been enrolled

Over 5 years ago leading minds within the Wellcome Trust and the Medical Research Council (MRC) realised that charting the entire genome of one human would do nothing to improve health. They argued that the real meaning and significance of genes could only be unravelled by also studying their owners’ behaviours and environments to determine which combinations conferred resilience and which resulted in disease. And so the idea of the UK Biobank was born.

  • Konrad Jamrozik1
  • David P Weller2
  • Richard F Heller3

  • 1 Department of Primary Care and Social Medicine, Imperial College of Science, Technology and Medicine, London, UK.
  • 2 Department of General Practice, Division of Community Health Sciences, University of Edinburgh, Edinburgh, UK.
  • 3 Evidence for Population Health Unit, School of Epidemiology and Health Sciences, University of Manchester, Manchester, UK.


Competing interests:

Two of us (K J and D P W) are members of Regional Collaborating Centres of UK Biobank and are bound by confidentiality agreements that preclude disclosure of certain documents relating to the project. However, the information in this article is all on UK Biobank’s website:


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.